| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf2d37fb8041db82befb3065684c82b7 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate |
2013-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9dd72c501465873fea56eb7e1945c62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f356d8cff362c4123136b4fb04a3113c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c551b72182916cb367064a03b1bf1de9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1528a5d92032d1a54f04ff072e010c7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac6b8f994306f9ed3ff90fa6a6e3fa1f |
| publicationDate |
2013-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2013204527-A1 |
| titleOfInvention |
Growth hormones with prolonged in-vivo efficacy |
| abstract |
The invention relates to growth hormone compounds with a protracted profile. The effect is obtained by linking an albumin binding residue via a hydrophilic spacer to 5 growth hormone variants. Further described are methods of preparing and using such compounds. These growth hormone compounds are based on there althered profile considered particular useful in therapy. |
| priorityDate |
2010-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |